Lockheed locks in a massive 850-jet F-35 deal — long defense while markets wobble

Verdict: the F-35 thesis deserves a watch, not a buy — wait for a firm contract and a cooled-off price

Our stance for the next three months is wait: the business case behind the 850-jet F-35 deal is credible and partly confirmed by the June 2026 quarter, but neither the contract nor the entry conditions are real yet. The strongest support is the cash evidence — Lockheed's free cash flow swung from negative $291 million in Q1 to positive $2.9 billion in Q2, Northrop's from negative $1.8 billion to $978 million, and both rank in the 99th percentile of Industrials peers on free cash flow. The strongest objection is that the deal is still only an "initial" agreement per the October 22 Reuters report, while Lockheed's own history shows gross margin collapsing to 3.7% in Q4 2024 and 4.0% in Q2 2025 on program charges, and provisional September 30 ownership filings show net insider selling at both companies. On top of that, both stocks are extremely extended — RSI of 88.3 on LMT at $597 versus a $538 50-day average — and the entry rule as compiled cannot ever fire, so there is no validated signal to act on. A signed contract with firm quantities and pricing, or a deal that shrinks or stalls, would flip this verdict in either direction.

Trade now

The business thesis is attractive on its own terms: an 850-jet F-35 deal would give Lockheed roughly a decade of government-funded revenue, and Q2 results (period ended June 28, 2026) support the cash story — free cash flow swung from negative $291M in Q1 to positive $2.9B, revenue rose 11.3% quarter over quarter to $20.1B, and net margin improved to about 9%. Northrop showed the same pattern, with free cash flow turning positive at $978M and revenue up 10.1% to $10.9B. But attractive thesis is not the same as a live entry, and today's conditions fail on both levels. First, the price condition: this is a wait-for-a-pullback setup. The entry rules want LMT trading near or below its 50-day exponential moving average (currently $538.13) while momentum has reset, yet LMT closed at $597.02 — about $59, or roughly 11%, above that level — and its 14-day RSI, a 0–100 momentum gauge, sits at an extremely hot 88.3. Northrop is similar: $546.77 versus a 50-day EMA of $519.30, with RSI at 77.6. The trade is also defined as a short swing (2% stop, 4% target, 90-day time exit), not a decade-long hold on the F-35 backlog. Second, there is a structural problem: as written, each entry rule requires RSI to be at or below 45 and above 50 at the same time, which can never be true. That is why no entries were recorded in the evaluated sample — the setup cannot fire as compiled, and no robust parameter alternative has been established yet (an optimization was requested, but no variant was recommended). Separately, historical performance was not measured because NOC's raw and adjusted price series use different bases, so this idea carries no measured track record. Concretely, "wait" means: watch for a meaningful cooling in momentum — RSI back toward the mid-40s — and price retesting the 50-day EMA zone (around $538 for LMT, $519 for NOC) before treating any trigger as live. The downside that matters if you chased today: both names are extended well above their trend averages, so a routine momentum reset could easily take LMT back toward $540, roughly 10% below the last close. Until the trigger is logically satisfiable and the market pulls back to it, this stays a watch-list idea. Observations as of October 24, 2026, daily bars. ### Technical details Entry rules as supplied (both tickers, daily timeframe): long when the close is above the 50-day EMA, or below it, with RSI (14) at or below 45 and also above 50 — the contradictory RSI pair means no entry can ever trigger in the current configuration. Observed values (as of 2026-10-24 16:26 UTC, daily bars): - LMT: last close $597.02; 50-day EMA $538.13 (price is $58.89 above it — the "price above EMA" condition is met, "below" is far); RSI (14) 88.3, versus thresholds of at-or-below 45 (far) and above 50 (met). Nearest support $590; nearest resistance $594.26, then $600. - NOC: last close $546.77; 50-day EMA $519.30 (price is $27.47 above it); RSI (14) 77.6. Nearest support $541.79; nearest resistance $552.34. Exit framework as supplied: take profit near the second-ranked resistance level or at +4.0% on the position; stop at -2.0% or below the second-ranked support; mandatory exit after 90 daily bars. Position sizing is fixed-risk at 2% of the account per trade with a 25% maximum position weight. Reward-to-risk as written is 2:1 on the fixed 4%/2% bracket. At current prices, none of the entry conditions are simultaneously satisfiable, so no valid distance-to-trigger or entry-zone calculation can be quoted beyond the EMA retest levels above.

The bull case has real fundamentals behind it, not just a headline

Takeaway: the idea's demand story is supported by accelerating revenue, restored free cash flow, and a top-decile cash-generation profile at both Lockheed Martin and Northrop Grumman, though the trade itself remains an untriggered watch-list setup. ### A confirmed demand catalyst of unusual size Per Reuters (October 22, 2026), Lockheed and the Pentagon struck an initial deal to produce 850 F-35 jets. The idea argues this gives roughly a decade of visible, government-funded revenue that does not depend on consumer demand or AI capex cycles. That is the right kind of demand for a jittery market: a single signed program can stabilize the revenue base regardless of what risk appetite does, and the same rotation logic supports peers like Northrop. The key word in the sourcing is "initial" — what remains to be proven is whether the deal converts into funded backlog on the next booking cycle. ### Lockheed's results already reflect the demand strength Lockheed's Q2 2026 (period ended June 28, 2026) revenue rose 11.3% quarter over quarter to $20.06B, net income rose 23.4% to $1.84B, and net margin improved to 9.15% from 8.26%. Operating cash flow swung from $220M in Q1 to $3.24B, and free cash flow — cash from operations minus capital spending — swung from negative $291M to positive $2.92B. For a business whose thesis is steady, contract-backed cash, this is exactly the shape you want to see: revenue and cash arriving together, not just on paper. ### Northrop validates the sector read, with a cleaner margin profile Northrop's Q2 2026 revenue rose 10.1% quarter over quarter to $10.88B with net margin at 10.06%, up from 8.86%, and free cash flow turned positive at $978M after a negative $1.82B Q1. Its full-year 2025 net margin of 12.18% (Q4 2025) sits above Lockheed's 6.61%, so if the bull case is really a sector rotation, Northrop offers the higher-margin way to express it. Both names also sit in the 99th percentile of Industrials peers on free cash flow ($2.76B for Lockheed, $3.24B for Northrop in Q4 2025), reinforcing the defensive-cash argument at the heart of the thesis. ### Dividends are growing, which raises the bar for the bull case to fail Lockheed raised its annual dividend from $10.60 per share in 2021 to $13.35 in 2025 (about 4.6% annual growth), with a trailing twelve-month payout of $13.80; Northrop grew its annual total from $6.16 to $8.99 over the same span (about 9.4% growth). Management only commits to that trajectory when cash flows are…

Scores

• Conviction score breakdown: 42
• Thesis support: 60
• Trade readiness: 20
• Risk quality: 45
• Trigger proximity: 15
• Fundamentals trend: 70

Watch items

• LMT — Close vs 50-day EMA
• LMT — RSI (14)
• NOC — Close vs 50-day EMA
• NOC — RSI (14)
• LMT — F-35 production deal confirmation